<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-viruses-10-00560">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Tsang</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Gorse</surname>
    <given-names>G.J.</given-names>
   </name>
   <name>
    <surname>Strout</surname>
    <given-names>C.B.</given-names>
   </name>
   <name>
    <surname>Sperling</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Greenberg</surname>
    <given-names>D.P.</given-names>
   </name>
   <name>
    <surname>Ozol-Godfrey</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>DiazGranados</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Landolfi</surname>
    <given-names>V.</given-names>
   </name>
  </person-group>
  <article-title>Immunogenicity and safety of fluzone Â® intradermal and high-dose influenza vaccines in older adults &gt;/=65 years of age: A randomized, controlled, phase II trial</article-title>
  <source>Vaccine</source>
  <year>2014</year>
  <volume>32</volume>
  <fpage>2507</fpage>
  <lpage>2517</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2013.09.074</pub-id>
  <?supplied-pmid 24120672?>
  <pub-id pub-id-type="pmid">24120672</pub-id>
 </element-citation>
</ref>
